RETINAL NEOVASCULARISATION

This adverse event was reported 252 times

These drugs are most commonly taken by patients reporting RETINAL NEOVASCULARISATION:

# Drug Count
0 RANIBIZUMAB 58
1 BEVACIZUMAB 29
2 AFLIBERCEPT 27
3 ASPIRIN 16
4 TESTOSTERONE 15
5 ADALIMUMAB 14
6 ASPIRIN 325 MG 13
7 ASPIRIN 81 MG 13
8 METHOTREXATE SODIUM 13
9 BROLUCIZUMAB 11
See all common drugs associated with RETINAL NEOVASCULARISATION

RETINAL NEOVASCULARISATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PROPARACAINE HYDROCHLORIDE 3 0.0056
1 VERTEPORFIN FOR INJECTION 5 0.0034
2 TETRACAINE 1 0.0025
3 TROPICAMIDE 4 0.0024
4 RANIBIZUMAB 58 0.0022
5 RIFAPENTINE 1 0.0019
6 CEFUROXIME SODIUM 2 0.0016
7 PREDNISOLONE SODIUM PHOSPHATE 4 0.0016
8 PEMIGATINIB 1 0.0012
9 CONJUGATED ESTROGENS/BAZEDOXIFENE 1 0.0011
See all drugs enriched for association with RETINAL NEOVASCULARISATION